NCT00642122View on ClinicalTrials.gov

Adults With Moderate to Severe Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Asthma
Interventions
DRUG

Budesonide

0.5mg once daily

DRUG

Budesonide

1mg once daily

DRUG

Budesonide

1mg twice daily

DRUG

Budesonide

2mg once daily

DRUG

Budesonide

4.00mcg twice daily

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY